Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1998
RATIONALE: Interleukin-2 may stimulate a person\'s white blood cells to kill more cancer cells. PURPOSE: Phase I trial to study the effectiveness of interleukin-2 in treating children who have undergone bone marrow transplantation for acute myeloid leukemia.
Epistemonikos ID: 1c3154f30a5fcd41130e34d20ca8c7272620a4e9
First added on: May 03, 2024